|Articles|July 27, 2015
Janet Freeman-Daily on Genomic Testing for Lung Cancer Patients
Author(s)Janet Freeman-Daily
Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer.
Advertisement
Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer. We spoke with Freeman-Daily during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
After a Stage 4 Lung Cancer Diagnosis at 36, Heather Prather Finds Joy in Community
2
FDA Approves Pluvicto Plus Hormone Therapy for Certain Patients With Metastatic Prostate Cancer
3
Imfinzi Combo Cuts Risk of Death by 25% in Advanced Biliary Tract Cancer
4
Tafinlar Plus Mekinist Triples Progression-Free Survival in Thyroid Cancer
5